Streetbeat News

Earnings

VEEV

Veeva Systems has revised its FY25 revenue forecast to $2.725B-$2.740B, slightly below the previous estimate of at least $2.75B. The company also projects an adjusted EPS of $6.16, which is above the estimated $5.57. This guidance is for the fiscal year ending January 31, 2025, including non-GAAP operating income of about $1.07B.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:41 pm

AMWD

STRL

TPC

Three industrial stocks, American Woodmark Corporation (AMWD), Tutor Perini Corporation (TPC), and Sterling Infrastructure, Inc. (STRL), are considered overbought as of March 1, 2024, based on their RSI values. AMWD reported strong Q3 earnings but saw a slight stock decline, TPC showed revenue growth and a significant stock increase, and STRL reported record earnings with a modest stock gain.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 1:37 pm

BIVI

FSR

NYCB

Fisker (FSR) shares plummeted by 41% due to disappointing Q4 results and doubts about its ongoing viability. New York Community Bancorp (NYCB) fell 31% after revealing material weaknesses in its internal controls. Conversely, BioVie (BIVI) surged 236% on promising data for its NE3107 treatment for Parkinson's and Alzheimer's, to be presented at a 2024 conference.

Portfolio Pulse from ryanfaloona@benzinga.com

March 01, 2024 | 1:36 pm

EGLE

Eagle Bulk Shipping (NYSE:EGLE) reported Q4 earnings of $1.13 per share, surpassing the $0.71 estimate, and sales of $104.59M, exceeding the $92.51M estimate. However, this represents a decrease from the previous year's earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:36 pm

TGT

Target Corporation (NYSE:TGT) offers a 2.88% annual dividend yield, equating to $1.10 per share quarterly or $4.40 annually. To earn $500 monthly from dividends, an investment of approximately $208,583 or 1,364 shares is needed. The article also highlights Target's upcoming Q4 earnings release on March 5, 2024, with expected earnings of $2.41 per share and revenue of $31.83 billion. Additionally, Target announced a collaboration with Diane von Furstenberg for a spring collection.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 1:33 pm

EOLS

Evolus, Inc. (NASDAQ:EOLS) announced its dermal filler product (Evolysse™/Estyme® Lift) showed statistical superiority over Restylane-L in a European study, meeting its primary endpoint of non-inferiority at 3 and 6 months. The company plans to launch the first-generation Cold HA Technology globally in 2025, with FDA filing expected in summer 2024. The study, which enrolled 45 patients, demonstrated the safety and effectiveness of the Evolysse™/Estyme® Lift filler. Additionally, Evolus has entered into exclusive distribution agreements with Symatese for the US and Europe, expanding its market by 78% to approximately $6 billion.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:32 pm

SLS

SELLAS Life Sciences announced successful Phase 1 results for SLS009 in treating acute myeloid leukemia (AML) at the 2024 European School of Haematology Conference. The study met all objectives, including pharmacokinetic, pharmacodynamic, safety, and clinical activity. A notable achievement was a complete remission (CR) in a patient after three months, lasting eight months, with one-year survival at the latest assessment. This marks the first instance of CR with CDK9 inhibition monotherapy in a relapsed/refractory AML patient. Phase 2a data is expected in March and Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:31 pm

NTAP

NetApp, Inc. (NASDAQ:NTAP) shares surged by approximately 17% in pre-market trading following the announcement of better-than-expected third-quarter financial results and positive guidance. The company reported adjusted earnings of $1.94 per share, surpassing the market estimates of $1.69 per share, with quarterly sales of $1.610 billion against expectations of $1.591 billion. Other stocks also showed significant movement in pre-market trading, with notable gainers including Nxu, Inc., Minim, Inc., and Dell Technologies Inc., among others. Conversely, several companies experienced declines, such as GigCapital5, Inc., Fisker Inc., and Sidus Space, Inc.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 1:31 pm

GDRX

GoodRx Holdings, Inc. (NASDAQ:GDRX) reported higher than expected Q4 FY23 results, with a 7% Y/Y increase in revenue to $196.6 million and adjusted EBITDA rising to $57.3 million. The company also announced a new $450 million stock repurchase program and provided FY24 revenue guidance above consensus. Following the earnings report, analysts from Barclays, JP Morgan, and TD Cowen raised their price targets on GoodRx shares, which surged 20.4% to close at $7.79.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 1:23 pm

WYNN

Wynn Resorts, Ltd (NASDAQ:WYNN) stock experienced a Golden Cross, indicating a bullish run, with a 15.5% increase year-to-date. This uptrend is supported by a recovery in the gaming market, strong performance in Las Vegas and Macau properties, favorable macroeconomic conditions, and positive consumer spending trends. Analyst consensus rates WYNN as a Buy, with price targets between $107 to $128, highlighting strong financial results and strategic event-driven revenue as key drivers for continued momentum into FY24.

Portfolio Pulse from Surbhi Jain

March 01, 2024 | 1:19 pm